Lisa A. Fulchino

发表

Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval

E. Campbell, A. Kesselheim, J. Avorn, 2016, PloS one.

Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes

A. Kesselheim, J. Gagne, J. Polinski, 2015, Drugs.

“Impact of drug‐reimbursement policies on prescribing: A case‐study of a newly marketed long‐acting injectable antipsychotic among relapsed schizophrenia patients”

James R. Rogers, S. Schneeweiss, H. Mogun, 2018, Pharmacoepidemiology and drug safety.

Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis

James R. Rogers, D. Solomon, Seoyoung C. Kim, 2015, PloS one.

Prescription drug insurance coverage and patient health outcomes: a systematic review.

Mary K. Kowal, T. Brennan, A. Kesselheim, 2015, American journal of public health.

PrescriptionDrugInsuranceCoverageandPatient HealthOutcomes:ASystematicReview

Mary K. Kowal, T. Brennan, A. Kesselheim, 2014 .

Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process

E. Campbell, A. Kesselheim, J. Gagne, 2017, Pharmacoepidemiology and drug safety.

Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence

A. Kesselheim, J. Gagne, J. Xie, 2017, Drugs.

Switch‐backs associated with generic drugs approved using product‐specific determinations of therapeutic equivalence

A. Kesselheim, J. Gagne, J. Xie, 2016, Pharmacoepidemiology and drug safety.

Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.

A. Kesselheim, A. Sarpatwari, C. Sacks, 2020, JAMA internal medicine.

Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey

E. Campbell, A. Kesselheim, J. Avorn, 2016, Journal of General Internal Medicine.